Two cancer research studies reveal essential role of neutrophils

Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.

The Clever Defence Mechanism of White Blood Cells

Study identifies how microbiome may affect pancreatic cancer outcomes - ecancer

Research from the Ren Lab includes collaboration with Lenny Shultz and Edison Liu.

The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications, Molecular Cancer

Surprise Finding Shows That Neutrophils Can Be Key Antitumor Weapons, Newsroom

Immune system and PI Immune Deficiency Foundation

Double-edged sword: Killing cancer cells can also drive tumour growth - ecancer

Neutrophil Blood Test: What High and Low Levels Mean

Scientists uncover a startling and exploitable coordination of gene expression in tumors

The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications, Molecular Cancer

Genetics of cancer therapy-associated cardiotoxicity - Journal of Molecular and Cellular Cardiology

Two Ludwig cancer research studies reveal essential role of neutrophils in immunotherapy – Scientific Inquirer